Last updated: May 28, 2026
VIBATIV Suppliers: Who Manufactures and Supplies Telavancin for Market Access, GPO, and Generic-Entry Risk
VIBATIV (telavancin) is supplied through the drug’s branded supply chain (drug substance and finished dose manufacturing) and, for access and procurement, through national distributors and institutional channels. Detailed, supplier-level identification (drug substance maker, finished-dose contract manufacturer, and current distributor roster) is required for procurement due diligence, but the provided input contains no verifiable supplier names, site locations, or FDA manufacturing site identifiers for telavancin products in the U.S.
What companies supply VIBATIV (telavancin) in the U.S. commercial supply chain?
Featured snippet: Supplier mapping for VIBATIV requires current manufacturer-of-record and FDA-registered manufacturing sites linked to the NDC. Those supplier names are not provided in the input.
What categories of “suppliers” matter for VIBATIV purchasing?
- Drug substance suppliers (API manufacturer of telavancin)
- Finished-dose manufacturers (final fill-finish and packaging)
- License holders and marketing authorization holders on FDA labels
- Wholesale distributors and GPO-managed channels
Which procurement sources typically list VIBATIV suppliers?
- FDA label “Manufactured for” and “Distributed by” lines on the current carton
- FDA Drug Registration and Listing System (DRLS) and NDC directory
- Datasets tied to manufacturing site inspections and drug product labeling
- Distributor catalog systems used for GPO bids
Which VIBATIV manufacturers are listed on the drug label and FDA registration?
Featured snippet: Manufacturer names on the VIBATIV label and corresponding FDA registration details determine the legally accountable “supplier” set. No label text or NDC identifiers were supplied.
How to interpret “manufactured for” vs “distributed by” on VIBATIV packaging
- “Manufactured for” generally identifies the finished-dose manufacturer or contract manufacturer with packaging responsibility.
- “Distributed by” points to the commercial distributor or marketing entity for wholesaling and accounts.
Why NDC-level mapping is required
VIBATIV strengths and package configurations can map to distinct manufacturing and labeling records. Supplier names should be tied to the exact NDC(s) in scope.
What contract manufacturers and API sites supply telavancin for VIBATIV?
Featured snippet: Contract manufacturing and API sourcing determine unit economics and supply continuity. Supplier names and site details were not provided.
Key diligence checkpoints used in supplier mapping
- API manufacturing site registration status (FDA DRLS)
- Sterile processing controls for the finished product, if applicable to the dosage form
- Change history and site transfer documentation
- Inspection history for the specific site(s)
Which distributors carry VIBATIV for hospital and specialty pharmacy procurement?
Featured snippet: Distributor coverage is typically defined at the NDC and strength level through major wholesalers and GPOs. No distributor list was provided.
Distributor roster typically includes
- National wholesalers that serve hospital purchasing
- Specialty distributors for channel-specific fulfillment
- GPO contracted supply listings used for formulary procurement
How do VIBATIV supply constraints affect pricing, availability, and contract terms?
Featured snippet: Availability risk flows from manufacturing site concentration, regulatory issues, and market exits. No VIBATIV supply event timeline or constraint data was provided.
Commercial impacts to model
- Backorder probability for specific NDCs
- Lead times under distributor allocation rules
- Margin changes under alternate sourcing
What supplier changes create FDA and quality/compliance risk for VIBATIV?
Featured snippet: Supplier substitution triggers CMC review impacts, labeling updates, and stability/bridging obligations. No supplier change events were provided.
Compliance triggers
- Site transfers for drug product or drug substance
- Process changes affecting critical quality attributes
- Packaging changes that require label reconciliation
What “supplier” information exists in the Orange Book and FDA databases for VIBATIV?
Featured snippet: Orange Book is for approval and listed patents, not supplier names. FDA label and NDC directories are the usual sources for manufacturer and distributor mapping. No Orange Book or NDC extract was provided.
How does VIBATIV supplier structure compare with other telavancin market players?
Featured snippet: If multiple telavancin products or strengths exist, supplier mapping differs by NDC. No competitor product set or NDCs were provided.
Comparison dimensions
- API supplier overlap
- Finished-dose manufacturer overlap
- Distributor coverage and contract terms
Key Takeaways
- VIBATIV supplier identification at the actionable level (API manufacturer, finished-dose manufacturer, manufacturer-of-record, and distributor roster) cannot be produced from the provided input.
- Supplier mapping for procurement and diligence must be anchored to the current NDC-specific FDA label and FDA registration records.
FAQs
- Where can I find the VIBATIV manufacturer-of-record for a specific NDC?
- How do I map VIBATIV distributors to hospital GPO contracts?
- What FDA data fields show telavancin drug product manufacturing sites?
- Do different VIBATIV strengths use the same finished-dose manufacturer?
- What documents should be requested for VIBATIV supplier change due diligence (CMC and labeling)?
References
- FDA. DRLS (Drug Registration and Listing System). U.S. Food and Drug Administration.
- FDA. NDC Directory (National Drug Code Directory). U.S. Food and Drug Administration.
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
